<DOC>
	<DOCNO>NCT00221182</DOCNO>
	<brief_summary>The purpose study determine stem cell therapy cell ( autologous cell ) deliver catheter region heart poor blood flow safe relieve chest pain , increase blood flow , and/or improve cardiac contractility ( function ) regenerate blood vessel heart .</brief_summary>
	<brief_title>Stem Cell Study Patients With Heart Disease</brief_title>
	<detailed_description>Chronic myocardial ischemia ( MI ) progressive disease , arise result atherosclerosis coronary artery . Prognosis chronic MI poor , effective treatment establish patient eligible traditional revascularization therapy angioplasty bypass procedure due inappropriate anatomy coronary artery frequent reocclusion follow revascularization . Therefore , necessary establish novel revascularization treatment improve prognosis no-option patient . We study safety clinical efficiency vascular regeneration mean transplantation autologous peripheral blood endothelial progenitor cell ( CD34 positive cell ) patient severe chronic coronary artery disease ( CAD ) eligible traditional revascularization treatment . The primary endpoint severity myocardial ischemia identify sestamibi SPECT stress myocardial scintigraphy evaluation adverse effect rate , secondary endpoint evaluation CCSAS NYHA classification , regional myocardial blood flow reveal PET scan , various leave ventricular function index .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Chest Pain</mesh_term>
	<criteria>Chronic severe CAD patient fulfil follow criterion consider suitable inclusion study . 1 . At least 6 month since last episode myocardial infarction least 3 month since initial anginal episode . 2 . Patients fulfil either follow criterion base extent CAD coronary angiography LVEF echocardiography . Patients single vessel CAD LVEF &lt; 50 % Patients multivessel CAD 3 . Reversible myocardial ischemia reveal sestamibi SPECT stress myocardial scintigraphy . 4 . Patients angioplasty bypass indicate anatomical procedural reason frequent reocclusion/restenosis follow traditional revascularization . 5 . Age 20 80 ( time consent ) . 6 . Exercise tolerance time ( ETT ) duration ≥ 3 minute &lt; 13 minute modify Bruce protocol 2 consecutive test ( &gt; 24 hour &lt; 2 week apart ) , difference 2 exercise time within 25 % mean ( Patients inform exercise restriction require entry study ) . 7 . Patients give informed consent write . Any one follow exclusion criterion sufficient disqualify patient study . 1 . Sustained ventricular tachycardia 24hour ECG . 2 . Chronic atrial fibrillation . 3 . Less 6 month since last episode cerebral infarction . 4 . Less 6 month since last coronary angioplasty le 3 month since last bypass surgery . 5 . Patients unstable angina , treatment rating 3 Braunwald system ( refer 5.4 . ) , severity III clinical rating B C. 6 . Presence leave ventricular thrombus echocardiography 7 . Patients malignant tumor* . 8 . Patients diabetic proliferate retinopathy** ( new Fukuda classification BI BV ) . 9 . Patients chronic rheumatoid arthritis . 10 . Patients history severe allergic reaction side effect GCSF preparation apheresis . 11 . Patients hematological disease ( leukemia , myeloproliferative disease , myelodysplastic syndrome ) . 12 . Patients currently suffer history interstitial pneumonitis . 13 . Patients cranial MRA reveal cerebral aneurysm . 14 . Patients abdominal CT ultrasonography reveals splenomegaly . 15 . Patients cirrhosis liver . 16 . Patients discontinue Warfarin . 17 . Leukocytes less 4,000/µL exceed 10,000/µL . 18 . Platelets le 100,000/µL . 19 . Hemoglobin le 10 g/dL . 20 . AST ( GOT ) exceed 100 IU/L ALT ( GPT ) exceed 100 IU/L . 21 . Patients impossible perform cardiac MRI leave ventriculography ( LVG ) ( see 9.2.4 cardiac MRI detail 9.2.9 LVG detail ) . 22 . Patients gate disturbance reason CAD ( critical limb ischemia , sciatic neuralgia , vasculitis ) , make exercise tolerance evaluation treadmill stress ECG difficult . 23 . Pregnant nursing patient , may pregnant , plan become pregnant end study period . 24 . Any reason Clinical Supervisors Clinical Researchers may consider case unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Angina</keyword>
	<keyword>Heart disease</keyword>
	<keyword>Pain</keyword>
	<keyword>Vascular disease</keyword>
</DOC>